Medtech InsightThe US Food and Drug Administration has revoked the emergency use authorization (EUA) of Chembio Diagnostics Inc. ’s DPP COVID-19 IgM/IgG test and analyzer system due to doubts about the accuracy of
Medtech InsightSerology, or antibody, tests promise to be one of the key tools in tracking and stopping the spread of COVID-19. But some manufacturers may be taking advantage of the ongoing pandemic by making mislea
Medtech InsightMedtech mergers and acquisition activity hit its lowest point for the year in November with only six deals recorded on Medtech Insight's M&A Tracker – significantly lower than the previous months
Medtech InsightChembio Diagnostics Inc. announced on Aug. 25 a fresh, $13.2m total contract from BARDA, HHS's Biomedical Advanced Research and Development Authority, so it can carry out development and commerciali